Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action inhibitors |
Mechanism MIF inhibitors(Macrophage migration inhibitory factor inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Preclinical | - | - | 01 May 2024 |





